Compare Revvity Inc (RVTY) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Summit Therapeutics Inc — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Revvity Inc and Summit Therapeutics Inc are close in size by market cap, and Revvity Inc pays a 0.26% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| RVTY | SMMT | |
|---|---|---|
Market Cap | $11.87B | $10.48B |
Sector | Technology | Health |
52-Week High | $117.75 | $29.32 |
52-Week Low | $82.26 | $13.05 |
Enterprise Value | $14.36B | $9.90B |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
